rg7388 and Lymphoma--Non-Hodgkin

rg7388 has been researched along with Lymphoma--Non-Hodgkin* in 1 studies

Other Studies

1 other study(ies) available for rg7388 and Lymphoma--Non-Hodgkin

ArticleYear
Chemotherapy-free, triple combination of obinutuzumab, venetoclax and idasanutlin: antitumor activity in xenograft models of non-Hodgkin lymphoma.
    Leukemia & lymphoma, 2018, Volume: 59, Issue:6

    Topics: Animals; Antibodies, Monoclonal, Humanized; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Drug Therapy, Combination; Humans; Lymphoma, Non-Hodgkin; Mice; para-Aminobenzoates; Pyrrolidines; Sulfonamides; Xenograft Model Antitumor Assays

2018